1. Home
  2. VRCA

VRCA

Verrica Pharmaceuticals Inc.

Logo Verrica Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Founded: 2013 Country:
United States
United States
Employees: N/A City: WEST CHESTER
Market Cap: 251.1M IPO Year: 2018
Target Price: $11.25 AVG Volume (30 days): 142.0K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.48 EPS Growth: N/A
52 Week Low/High: $2.86 - $7.76 Next Earning Date: 05-07-2024
Revenue: $5,124,000 Revenue Growth: -43.27%
Revenue Growth (this year): 377.73% Revenue Growth (next year): 181.73%

Share on Social Networks: